Drugs List

Drugs A-Z List - J
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Drugs List [Browse by brand or generic name]
Jadelle levonorgestrel) Implants - FDA

Description : Jadelle® (levonorgestrel implants unavailable in us) is a set of two flexible cylindric...

  • Indications
  • Jadelle® (levonorgestrel implants (unavailable in us)) implants are indicated for the prevention of pregnancy and are a long-term (up to 5 years) reversible method of cont
  •   Read More
Jadelle (levonorgestrel) Implants - FDA

Description : Jadelle® (levonorgestrel implants unavailable in us) is a set of two flexible cylindric...

  • Indications
  • Jadelle® (levonorgestrel implants (unavailable in us)) implants are indicated for the prevention of pregnancy and are a long-term (up to 5 years) reversible method of
  •   Read More
Jakafi  ruxolitinib (Pronunciation: RUX oh LI ti nib) - FDA

Description : Ruxolitinib phosphate is a kinase inhibitor with the chemical name (R)-3-(4-(7H-pyrrolo[2,3...

  • Indications
  • Myelofibrosis Jakafi is indicated for treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofib
  •   Read More
Jakafi ruxolitinib (Pronunciation: RUX oh LI ti nib) - Multum

Description : Ruxolitinib phosphate is a kinase inhibitor with the chemical name (R)-3-(4-(7H-pyrrolo[2,3...

  • Indications
  • Myelofibrosis Jakafi is indicated for treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofib
  •   Read More
Jakafi ruxolitinib (Pronunciation: RUX oh LI ti nib) - FDA

Description : Ruxolitinib phosphate is a kinase inhibitor with the chemical name (R)-3-(4-(7H-pyrrolo[2,3...

  • Indications
  • Myelofibrosis Jakafi is indicated for treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofib
  •   Read More
Jakafi ruxolitinib (Pronunciation: RUX oh LI ti nib) - Multum

Description : Ruxolitinib phosphate is a kinase inhibitor with the chemical name (R)-3-(4-(7H-pyrrolo[2,3...

  • Indications
  • Myelofibrosis Jakafi is indicated for treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofib
  •   Read More
Jalyn  dutasteride and tamsulosin (Pronunciation: doo TA - FDA

Description : JALYN (dutasteride and tamsulosin hydrochloride) Capsules contain dutasteride (a selective ...

  • Indications
  • Benign Prostatic Hyperplasia (BPH) Treatment JALYN™ (dutasteride and tamsulosin hydrochloride) Capsules are indicated for the treatment of symptomatic BPH in men wi
  •   Read More
Jalyn dutasteride and tamsulosin (Pronunciation: doo TAS - Multum

Description : JALYN (dutasteride and tamsulosin hydrochloride) Capsules contain dutasteride (a selective ...

  • Indications
  • Benign Prostatic Hyperplasia (BPH) Treatment JALYN™ (dutasteride and tamsulosin hydrochloride) Capsules are indicated for the treatment of symptomatic BPH in men wi
  •   Read More
Jalyn dutasteride and tamsulosin (Pronunciation: doo TAS - Multum

Description : JALYN (dutasteride and tamsulosin hydrochloride) Capsules contain dutasteride (a selective ...

  • Indications
  • Benign Prostatic Hyperplasia (BPH) Treatment JALYN™ (dutasteride and tamsulosin hydrochloride) Capsules are indicated for the treatment of symptomatic BPH in men wi
  •   Read More
Janumet XR (sitagliptin and metformin HCl) Extended-release T - FDA

Description : JANUMET XR tablets contain two oral antidiabetic medications used in the management of type...

  • Indications
  • JANUMET® XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin a
  •   Read More
Janumet XR (sitagliptin and metformin HCl) Extended-release T - FDA

Description : JANUMET XR tablets contain two oral antidiabetic medications used in the management of type 2 d...

  • Indications
  • JANUMET® XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin a
  •   Read More
Janumet, Janumet XR metformin and sitagliptin (Pronunciation: met FOR - Multum

Description : JANUMET (sitagliptin/metformin HCl) tablets contain two oral antihyperglycemic drugs used i...

  • Indications
  • JANUMET is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metfor
  •   Read More
Janumet, Janumet XR metformin and sitagliptin (Pronunciation: met FOR - FDA

Description : JANUMET (sitagliptin/metformin HCl) tablets contain two oral antihyperglycemic drugs used in th...

  • Indications
  • JANUMET is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metfor
  •   Read More
Janumet, Janumet XR metformin and sitagliptin (Pronunciation: met FOR - Multum

Description : JANUMET (sitagliptin/metformin HCl) tablets contain two oral antihyperglycemic drugs used in th...

  • Indications
  • JANUMET is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metfor
  •   Read More
Januvia  sitagliptin (Pronunciation: SI ta glip tin - FDA

Description : JANUVIA Tablets contain sitagliptin phosphate, an orally-active inhibitor of the dipeptidyl...

  • Indications
  • Monotherapy and Combination Therapy JANUVIA® is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. [See
  •   Read More
Januvia sitagliptin (Pronunciation: SI ta glip tin) - FDA

Description : JANUVIA Tablets contain sitagliptin phosphate, an orally-active inhibitor of the dipeptidyl pep...

  • Indications
  • Monotherapy And Combination Therapy JANUVIA® is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. [See
  •   Read More
Januvia  sitagliptin (Pronunciation: SI ta glip tin) - Multum

Description : JANUVIA Tablets contain sitagliptin phosphate, an orally-active inhibitor of the dipeptidyl pep...

  • Indications
  • Monotherapy And Combination Therapy JANUVIA® is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. [See
  •   Read More
Jardiance (empagliflozin) Tablets - FDA

Description : JARDIANCE tablets contain empagliflozin, an orally-active inhibitor of the sodium-glucose co-tr...

  • Indications
  • JARDIANCE is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies]. Limitatio
  •   Read More
Jardiance empagliflozin) Tablets - FDA

Description : JARDIANCE tablets contain empagliflozin, an orally-active inhibitor of the sodium-glucose c...

  • Indications
  • JARDIANCE is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies]. Limitation Of Use
  •   Read More
Je-Vax Japanese encephalitis virus vaccine (Nakayama) (Pr - FDA

Description : JE-VAX®, Japanese Encephalitis Virus Vaccine Inactivated, is a sterile, lyophilized vac...

  • Indications
  • JE-VAX (japanese encephalitis virus vaccine inactivated) is indicated for active immunization against JE for persons one year of age and older. For recommended primary imm
  •   Read More
Je-Vax Japanese encephalitis virus vaccine (Nakayama) (Pr - Multum

Description : JE-VAX®, Japanese Encephalitis Virus Vaccine Inactivated, is a sterile, lyophilized vac...

  • Indications
  • JE-VAX (japanese encephalitis virus vaccine inactivated) is indicated for active immunization against JE for persons one year of age and older. For recommended primary imm
  •   Read More
Je-Vax Japanese Encephalitis Virus Vaccine Inactivated - FDA

Description : JE-VAX®, Japanese Encephalitis Virus Vaccine Inactivated, is a sterile, lyophilized vac...

  • Indications
  • JE-VAX (japanese encephalitis virus vaccine inactivated) is indicated for active immunization against JE for persons one year of age and older. For recommended primary imm
  •   Read More
Je-Vax Japanese encephalitis virus vaccine (Nakayama) (Pr - Multum

Description : JE-VAX®, Japanese Encephalitis Virus Vaccine Inactivated, is a sterile, lyophilized vac...

  • Indications
  • JE-VAX (japanese encephalitis virus vaccine inactivated) is indicated for active immunization against JE for persons one year of age and older. For recommended primary imm
  •   Read More
Jenadueto (linagliptin and metformin hydrochloride) Tablets, - FDA

Description : JENTADUETO tablets contain 2 oral antihyperglycemic drugs used in the management of type 2 ...

  • Indications
  • Indication JENTADUETO tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with bot
  •   Read More
Jenloga (clonidine hydrochloride) Extended-Release Tablets - FDA

Description : Jenloga (clonidine hydrochloride) extended-release is a centrally acting alpha-2 adrenergic...

  • Indications
  • Jenloga (clonidine hydrochloride) extended-release is indicated for the treatment of hypertension. Jenloga (clonidine tablets) may be used alone or concomitantly with othe
  •   Read More
Jenloga clonidine hydrochloride) Extended-Release Tablets - FDA

Description : Jenloga (clonidine hydrochloride) extended-release is a centrally acting alpha-2 adrenergic...

  • Indications
  • Jenloga (clonidine hydrochloride) extended-release is indicated for the treatment of hypertension. Jenloga (clonidine tablets) may be used alone or concomitantly with othe
  •   Read More
Jentadueto linagliptin and metformin (Pronunciation: LIN a GL - Multum

Description : JENTADUETO tablets contain 2 oral antihyperglycemic drugs used in the management of type 2 ...

  • Indications
  • Indication JENTADUETO tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with bot
  •   Read More
Jentadueto linagliptin and metformin (Pronunciation: LIN a GL - FDA

Description : JENTADUETO tablets contain 2 oral antihyperglycemic drugs used in the management of type 2 ...

  • Indications
  • Indication JENTADUETO tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with bot
  •   Read More
Jentadueto linagliptin and metformin (Pronunciation: LIN a GL - Multum

Description : JENTADUETO tablets contain 2 oral antihyperglycemic drugs used in the management of type 2 ...

  • Indications
  • Indication JENTADUETO tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with bot
  •   Read More
Jetrea ocriplasmin) Injection - FDA

Description : Ocriplasmin is a recombinant truncated form of human plasmin with a molecular weight of 27....

  • Indications
  • JETREA® is a proteolytic enzyme indicated for the treatment of symptomatic vitreomacular adhesion.
  •   Read More
Jetrea ocriplasmin) Injection - FDA

Description : Ocriplasmin is a recombinant truncated form of human plasmin with a molecular weight of 27....

  • Indications
  • JETREA® is a proteolytic enzyme indicated for the treatment of symptomatic vitreomacular adhesion.
  •   Read More
Jevtana cabazitaxel (Pronunciation: ka BAZ i TAX el) - FDA

Description : JEVTANA (cabazitaxel) is an antineoplastic agent belonging to the taxane class. It is prepa...

  • Indications
  • JEVTANA® is a microtubule inhibitor indicated in combination with prednisone for the treatment of patients with hormone-refractory metastatic prostate cancer previousl
  •   Read More
Jevtana cabazitaxel (Pronunciation: ka BAZ i TAX el) - Multum

Description : JEVTANA (cabazitaxel) is an antineoplastic agent belonging to the taxane class. It is prepa...

  • Indications
  • JEVTANA® is a microtubule inhibitor indicated in combination with prednisone for the treatment of patients with hormone-refractory metastatic prostate cancer previousl
  •   Read More
Jevtana cabazitaxel (Pronunciation: ka BAZ i TAX el) - FDA

Description : JEVTANA (cabazitaxel) is an antineoplastic agent belonging to the taxane class. It is prepa...

  • Indications
  • JEVTANA® is a microtubule inhibitor indicated in combination with prednisone for the treatment of patients with hormone-refractory metastatic prostate cancer previously tr
  •   Read More
Jevtana  cabazitaxel (Pronunciation: ka BAZ i TAX el) - Multum

Description : JEVTANA (cabazitaxel) is an antineoplastic agent belonging to the taxane class. It is prepa...

  • Indications
  • JEVTANA® is a microtubule inhibitor indicated in combination with prednisone for the treatment of patients with hormone-refractory metastatic prostate cancer previously tr
  •   Read More
Jinteli northindrone acetate and ethinyl estradiol) Tablet - FDA

Description : Jinteli™ (norethindrone acetate and ethinyl estradiol tablets, USP) is a continuous d...

  • Indications
  • Jinteli™ (norethindrone acetate and ethinyl estradiol tablets, USP) are indicated in women with an intact uterus for the: Treatment of moderate to severe vasomoto
  •   Read More
Jinteli (northindrone acetate and ethinyl estradiol) Table - FDA

Description : Jinteli™ (norethindrone acetate and ethinyl estradiol tablets, USP) is a continuous d...

  • Indications
  • Jinteli™ (norethindrone acetate and ethinyl estradiol tablets, USP) are indicated in women with an intact uterus for the: Treatment of moderate to severe vasomoto
  •   Read More
Jublia (efinaconazole) Topical Solution - FDA

Description : JUBLIA (efinaconazole) topical solution, 10% is a clear colorless to pale yellow solution f...

  • Indications
  • JUBLIA (efinaconazole) topical solution, 10% is an azole antifungal indicated for the topical treatment of onychomycosis of the toenail (s) due to Trichophyton rubrum and Tri
  •   Read More
Jublia efinaconazole) Topical Solution - FDA

Description : JUBLIA (efinaconazole) topical solution, 10% is a clear colorless to pale yellow solution f...

  • Indications
  • JUBLIA (efinaconazole) topical solution, 10% is an azole antifungal indicated for the topical treatment of onychomycosis of the toenail (s) due to Trichophyton rubrum and Tri
  •   Read More
Juvisync simvastatin and sitagliptin (Pronunciation: SIM va - FDA

Description : JUVISYNC Tablets contain sitagliptin phosphate, an orally-active inhibitor of the dipeptidy...

  • Indications
  • JUVISYNC™ (sitagliptin and simvastatin) is indicated in patients for whom treatment with both sitagliptin and simvastatin is appropriate. Sitagliptin Sitagliptin i
  •   Read More
Juvisync  simvastatin and sitagliptin (Pronunciation: SIM v - Multum

Description : JUVISYNC Tablets contain sitagliptin phosphate, an orally-active inhibitor of the dipeptidy...

  • Indications
  • JUVISYNC™ (sitagliptin and simvastatin) is indicated in patients for whom treatment with both sitagliptin and simvastatin is appropriate. Sitagliptin Sitagliptin i
  •   Read More
Juvisync simvastatin and sitagliptin (Pronunciation: SIM va - FDA

Description : JUVISYNC Tablets contain sitagliptin phosphate, an orally-active inhibitor of the dipeptidyl pe...

  • Indications
  • JUVISYNC™ (sitagliptin and simvastatin) is indicated in patients for whom treatment with both sitagliptin and simvastatin is appropriate. Sitagliptin Sitagliptin i
  •   Read More
Juvisync simvastatin and sitagliptin (Pronunciation: SIM va - Multum

Description : JUVISYNC Tablets contain sitagliptin phosphate, an orally-active inhibitor of the dipeptidyl pe...

  • Indications
  • JUVISYNC™ (sitagliptin and simvastatin) is indicated in patients for whom treatment with both sitagliptin and simvastatin is appropriate. Sitagliptin Sitagliptin i
  •   Read More
Juxtapid lomitapide (Pronunciation: loe MI ta pide) - FDA

Description : JUXTAPID capsules contain lomitapide mesylate, a synthetic lipid-lowering agent for oral ad...

  • Indications
  • Homozygous Familial Hypercholesterolemia JUXTAPID is indicated as an adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where availa
  •   Read More
Juxtapid lomitapide (Pronunciation: loe MI ta pide) - Multum

Description : JUXTAPID capsules contain lomitapide mesylate, a synthetic lipid-lowering agent for oral ad...

  • Indications
  • Homozygous Familial Hypercholesterolemia JUXTAPID is indicated as an adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where availa
  •   Read More
Juxtapid lomitapide (Pronunciation: loe MI ta pide) - FDA

Description : JUXTAPID capsules contain lomitapide mesylate, a synthetic lipid-lowering agent for oral ad...

  • Indications
  • Homozygous Familial Hypercholesterolemia JUXTAPID is indicated as an adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where availa
  •   Read More
Juxtapid lomitapide (Pronunciation: loe MI ta pide) - Multum

Description : JUXTAPID capsules contain lomitapide mesylate, a synthetic lipid-lowering agent for oral ad...

  • Indications
  • Homozygous Familial Hypercholesterolemia JUXTAPID is indicated as an adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where availa
  •   Read More
Rx Scoops
Featured Topics
Advertisements
Copyrights ©2014: Rx Scoops - Designed & Developed By - GOIGI